Reagen 8 RPATK - test for eight respiratory pathogens, including COVID-19
Reagen 8 RPATK - test for eight respiratory pathogens, including COVID-19
Reagen 8 RPATK - test for eight respiratory pathogens, including COVID-19
Reagen 8 RPATK - test for eight respiratory pathogens, including COVID-19

Reagen 8 RPATK - test for eight respiratory pathogens, including COVID-19

CZK 99.00
CZK 88.39 excl. VAT i
The applicable VAT rate is 12% – Czech Republic.
Delivery 1-2 working days

The kit is used for rapid detection of COVID-19, influenza A virus, influenza B virus, respiratory syncytial virus (RSV), adenovirus (ADV), M. pneumoniae (MP), parainfluenza virus (PIV) and CP antigen in a nasal swab. You will know the result in 10 minutes.

Reference
RNS92175
In stock
Reagen 8 RPTK – rapid antigen test for 8 respiratory pathogens
When the test is useful
Acute respiratory infections are among the most common infectious diseases, and they are often caused by viruses or other non-bacterial pathogens. Clinical manifestations mainly include rhinitis, pharyngitis, laryngitis, tonsillitis and, in more severe cases, tracheitis, bronchitis or pneumonia.
Eight Respiratory Pathogens Antigen Rapid Test Kit is a qualitative immunochromatographic assay intended for detection of COVID-19, influenza A, influenza B, RSV, adenovirus, Mycoplasma pneumoniae, parainfluenza virus and Chlamydia pneumoniae antigens from a nasal swab. The result can be read in about 10 minutes.
According to the manufacturer’s instructions, the test is intended for in vitro diagnostic use. The result should be interpreted together with clinical symptoms, medical history and epidemiological information and must not be the sole basis for treatment decisions.
The test is suitable for rapid screening of eight common respiratory pathogens from a nasal swab in a single test.
  • When symptoms of acute respiratory infection are present, such as runny nose, sore throat, cough or fever.
  • For rapid differentiation of several possible viral and atypical causes in one examination.
  • When a quick screening result is needed without laboratory instrumentation.
  • As a supplementary examination before confirmation by another laboratory method, such as PCR.
Main benefits
  • Simultaneous detection of 8 respiratory pathogens in one test.
  • Rapid result in about 10 minutes.
  • Nasal swab as the specimen type.
  • Immunochromatographic method with visual reading of coloured lines.
  • The control line confirms correct chromatography flow and test validity.
Easy to use
  • Before sampling, blow your nose and allow the test device and extraction buffer to reach room temperature of 20 to 30 °C.
  • Insert the sterile swab about 1.5 to 2 cm into the nostril, or up to 1.2 cm for small children, rotate several times and repeat in the other nostril using the same swab.
  • Immerse the swab into the extraction tube, rotate and squeeze it 5 times, then close the tube and shake gently for about 5 seconds.
  • Apply 3 drops of the mixed specimen vertically into the sample well.
  • Read the result after 10 minutes; results after 20 minutes are not valid.
Warning: A negative result does not exclude infection, especially when the antigen level is low or the specimen collection is inadequate. Both positive and negative findings should be assessed in the context of the clinical picture and confirmed by laboratory testing when needed.
Kit contents
The test kit contains everything needed to perform the examination:
  • test cassette,
  • sterile swab,
  • sample extraction buffer,
  • instructions for use.
Clinical performance
The manufacturer reports clinical evaluation against RT-PCR or nucleic acid tests for the individual pathogens. For COVID-19, the reported sensitivity was 96.20% and specificity 98.90%; for RSV sensitivity 96.84% and specificity 99.45%; for influenza A/B sensitivity 97.47% and specificity 99.45%; for adenovirus sensitivity 98.10% and specificity 98.90%; for Mycoplasma pneumoniae sensitivity 99.37% and specificity 99.45%; for parainfluenza sensitivity 97.47% and specificity 98.90%; and for Chlamydia pneumoniae sensitivity 98.72% and specificity 99.45%.
Parameter Value
Measured parameters Antigens of COVID-19, Flu A, Flu B, RSV, ADV, MP, PIV and CP
Sensitivity Approximately 96.20% to 99.37%, depending on the pathogen
Specificity Approximately 98.90% to 99.45%, depending on the pathogen
Read time Read after 10 minutes; results after 20 minutes are invalid
Storage
  • Store the test at 2 to 30 °C and protect it from direct sunlight.
  • After opening the foil pouch, the test should be used within 1 hour.
  • Specimens should be processed as soon as possible after collection, ideally within 30 minutes.
  • Do not freeze the specimen or transport it for later testing.
Additional information
The test is intended for qualitative detection of antigens from a nasal swab and cannot determine the quantitative level of individual markers.
According to the manufacturer, no cross-reactivity with the listed tested organisms was observed and no effect of the listed interfering substances at the tested concentrations was demonstrated.
An invalid result occurs when the control line C does not appear; in such a case, the test must be repeated with a new cassette.
Technical parameters
Test type Rapid qualitative immunochromatographic in vitro test
Measured parameters COVID-19, Flu A, Flu B, RSV, ADV, MP, PIV, CP
Specimen Nasal swab
Result About 10 minutes
Kit contents Cassette, sterile swab, extraction buffer, instructions
Storage 2 to 30 °C, protect from sunlight
Intended use For in vitro diagnostic use
Interpretation Positive result = control line C plus the relevant test line; negative result = control line C only

Reagen_Respiratory_8_Navod

Download (345.92KB)

Data sheet

Expiration date:
2027-07

Other products from the same category